Kerwar S S, Sloboda A E
Agents Actions. 1982 Apr;12(1-2):216-20. doi: 10.1007/BF01965149.
The effect of fenbufen and sulindac, two novel antiinflammatory agents, on the developing and established lesion of type II collagen arthritis was investigated. Using paw diameter and radiology as parameters, these studies suggest that fenbufen is more efficacious than sulindac in this model.
研究了两种新型抗炎药芬布芬和舒林酸对Ⅱ型胶原性关节炎的发展期和已形成病变的影响。以爪直径和放射学为参数,这些研究表明在该模型中芬布芬比舒林酸更有效。